Friedreich Ataxia
📧 Sign up to get email alerts when something new happens for Friedreich Ataxia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-28Clinical Trial Update: A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia [Phase 1]
The Phase 1 trial of nomlabofusp in adolescents and children with Friedreich's Ataxia has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: A Study of ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia [Phase 1]
A Phase 1 trial of ASP2016 in adults with Friedreich Ataxia-associated cardiomyopathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-08Clinical Trial Update: Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia
The clinical trial NCT06560346, sponsored by Friedreich's Ataxia Research Alliance, has been withdrawn; it previously sought to understand t…
-
EMA withdrawal · 2009-12-31EMA Refused: Sovrima (idebenone) — Centocor B.V.
The EMA refused the marketing authorization for Sovrima (idebenone) by Centocor B.V. for Friedreich ataxia.